Guidelines for diagnosis and management of the cobalamin‐related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency
Year: 2016
Type: review
Abstract: BACKGROUND: Remethylation defects are rare inherited disorders in which impaired remethylation of homocysteine to methionine leads to accumulation of homocysteine and perturbation of numerous methylation reactions. OBJECTIVE: To summarise clinical and biochemical characteristics of these severe disorders and to provide guidelines on diagnosis and management. DATA SOURCES: Review, evaluation and discussion of the medical literature (Medline, Cochrane databases) by a panel of experts on these rare diseases following the GRADE approach. KEY RECOMMENDATIONS: We strongly recommend measuring plasma total homocysteine in any patient presenting with the combination of neurological and/or visual and/or haematological symptoms, subacute spinal cord degeneration, atypical haemolytic uraemic syndrome or unexplained vascular thrombosis. We strongly recommend to initiate treatment with parenteral hydroxocobalamin without delay in any suspected remethylation disorder; it significantly improves survival and incidence of severe complications. We strongly recommend betaine treatment in individuals with MTHFR deficiency; it improves the outcome and prevents disease when given early.
Authors: Martina Huemer, Daria Diodato, Bernd Schwahn, Manuel Schiff, Anabela Bandeira, Jean‐Francois Benoist, Alberto Burlina, Roberto Cerone, Maria L. Couce, Angeles Garcia‐Cazorla, Giancarlo la Marca, Elisabetta Pasquini, Laura Vilarinho, James D. Weisfeld‐Adams, Viktor Kožich, Henk Blom, Matthias R. Baumgartner, Carlo Dionisi‐Vici
Institutions: University of Zurich, University Children's Hospital Zurich, Bambino Gesù Children's Hospital, Manchester Academic Health Science Centre, St Mary's Hospital, Inserm, Sorbonne Paris Cité, Assistance Publique – Hôpitaux de Paris, Hôpital Robert-Debré, Université Paris Diderot, NeuroDiderot, Centro Hospitalar do Porto, Université Paris-Sud, University of Padua, Azienda Ospedale - Università Padova, Istituto Giannina Gaslini, University of Genoa, Centro de Investigación Biomédica en Red, Instituto de Investigación Sanitaria de Santiago, Hospital Sant Joan de Déu Barcelona, Instituto de Salud Carlos III, Centre for Biomedical Network Research on Rare Diseases, University of Florence, Meyer Children's Hospital, Children's Hospital Colorado, University of Colorado Anschutz, University of Colorado Denver, Charles University, General University Hospital in Prague, University of Freiburg, University Medical Center Freiburg
Language: English
Subfield: Clinical Biochemistry
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $3,470
OpenAlex ID: W2557591007
